Background This study examined the safety and immunogenicity of an inactivated SARS-CoV-2
vaccine. Method In a phase I randomized, double-blinded, placebo-controlled trial …

Background We evaluated an inactivated SARS-CoV-2 vaccine for immunogenicity and
safety in adults aged 18-59 years. Methods In this randomized, double-blinded and controlled …

Background We evaluated an inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
vaccine for immunogenicity and safety in adults aged 18–59 years. Methods …

Background This study was conducted to describe present and changing trends in surgical
modalities and neoadjuvant chemotherapy (NACT) in female breast cancer patients in China …

As a recently launched novel vaccine used as one of the vaccines for the final eradication of
polios worldwide, complete data on the consistency and immunogenicity characteristics of …

BACKGROUND In-depth investigations of the safety and immunogenicity of inactivated
SARS-CoV-2 vaccines are needed. METHOD In a phase I randomized, double-blinded, and …

Background and objective: Adherence to oral anticoagulants is crucial for the prevention of
ischemic stroke in atrial fibrillation patients; however, evidence of oral-anticoagulant …

To investigate whether the TNF-α, IL-2, IL-4 and IL-10 genes contribute to variations in
vaccine-induced immune responses after immunization with the inactivated Japanese …

To provide a basis for further optimization of the polio sequential immunization schedule,
this study evaluated the effectiveness of booster immunization with one dose of bivalent oral …

Background Mumps vaccine immunizations have reduced the incidence of this disease.
With the variation of mumps circulating strain, novel vaccine strains are always important. …